EUVIMEDEUVIMED entdecken
Crossref

A 10-year retrospective study of neonatal lupus erythematous in China

Yingfang Yu, Lizhong Du, Jiarong Pan, Jiyan Zheng, An Chen, Lihua Chen

Asian Pacific Journal of Allergy and Immunology · 2016 · 34 (2)

DOI: 10.12932/ap0671.34.2.2016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Pacific Journal of Allergy and Immunology, 2016. Verfasst von Yingfang Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Griffith Health Institute - Griffith University, Gold Coast, QLD, Australia. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Neonatal lupus erythematosus (NLE) is not a common disease. The death rate of complete congenital heart block (CCHB), which is the most severe clinical manifestation, is as high as 20% to 30%, so early recognition of infants at risk is important. OBJECTIVES: To investigate the clinical features and long-term prognosis of NLE. METHODS: Twenty-five cases with NLE were reviewed. The clinical manifestations of patients and their mothers were summarized and analyzed. Autoantibodies were detected, and long-term follow-up was carried out. RESULTS: There were 25 patients (male:female ratio of 11:14). CCHB was detected in only 3 of the 25 patients (12%). Cutaneous neonatal lupus erythematosus (CNLE) was seen in 22 of the 25 patients (88%). Eight babies were treated with intravenous immunoglobulin (IVIG), five of whom had a prolonged PR interval that reverted to normal sinus rhythm. During the follow-up of the patients, we found only two patients with CCHB without a pacemaker, who both exhibited growth delay. One patient with CCHB without a pacemaker died. CONCLUSIONS: Children with NLE have an excellent outcome when only skin lesions are present. Even the hepatic, hematological and neurological abnormalities are transient, with generally good outcomes. IVIG might have some effectiveness due to enhanced anti-inflammatory activity to treat early diseases that may be reversible (e.g. prolonged PR interval). The long-term prognosis for patients with NLE is still under investigation, and some infants with NLE may progress to other autoimmune diseases later in childhood.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, AntinuclearBiomarkersChinaFemaleHeart BlockHumansImmunoglobulins, IntravenousImmunosuppressive AgentsInfant, NewbornLupus Erythematosus, CutaneousLupus Erythematosus, SystemicMalePacemaker, ArtificialRetrospective StudiesTime FactorsTreatment Outcome

Substanzen

Antibodies, AntinuclearBiomarkersImmunoglobulins, IntravenousImmunosuppressive AgentsSS-A antibodiesSS-B antibodies

Autor:innen und Institutionen

  • Griffith Health Institute - Griffith University, Gold Coast, QLD, Australia.

Zitieren

APA

Yu, Y., Du, L., Pan, J., Zheng, J., Chen, A., & Chen, L. (2016). A 10-year retrospective study of neonatal lupus erythematous in China. Asian Pacific Journal of Allergy and Immunology, 34(2). https://doi.org/10.12932/ap0671.34.2.2016

Vancouver

Yu Y, Du L, Pan J, Zheng J, Chen A, Chen L. A 10-year retrospective study of neonatal lupus erythematous in China. Asian Pacific Journal of Allergy and Immunology. 2016;34(2). doi:10.12932/ap0671.34.2.2016

BibTeX
@article{Yu2016,
  author = {Yu, Yingfang and Du, Lizhong and Pan, Jiarong and Zheng, Jiyan and Chen, An and Chen, Lihua},
  title = {A 10-year retrospective study of neonatal lupus erythematous in China},
  journal = {Asian Pacific Journal of Allergy and Immunology},
  year = {2016},
  volume = {34},
  number = {2},
  doi = {10.12932/ap0671.34.2.2016}
}
Kostenlos starten →